Aktienanalyse zu Aimei Health Technology Co Ltd (AFJK)

KI-Analyse of Aimei Health Technology Co Ltd (AFJK)

Halten

Aimei Health Technology Co Ltd (AFJK) is currently not a strong buy. The stock is trading at $12.20, significantly down 83.92% year-to-date, indicating severe volatility and potential instability. The RSI is at 50.187, suggesting it is neither overbought nor oversold, but the forward P/E ratio is 0, indicating a lack of earnings expectations. The company has recently faced negative news, including a failure to file its quarterly report on time and the termination of a merger agreement, which has likely shaken investor confidence. The main risk is the company's recent net income drop to -83,144 USD in Q2 2026, which raises concerns about its financial health. Overall, while there may be potential for recovery, the current situation warrants a cautious approach and a hold position for now.

Bewertungskennzahlen

Das aktuelle erwartete KGV von Aimei Health Technology Co Ltd (AFJK) beträgt 0.00, verglichen mit dem 5-Jahres-Durchschnitt von 0.00.

Erwartetes KGV

Stark unterbewertet

5J-Durchschnitt P/E

0.00

Aktuelles P/E

0.00

Überbewertet

0.00

Unterbewertet

0.00

Erwartetes EV/EBITDA

Stark unterbewertet

5J-Durchschnitt EV/EBITDA

0.00

Aktuelles EV/EBITDA

0.00

Überbewertet

0.00

Unterbewertet

0.00

Erwartetes KUV

Fair bewertet

5J-Durchschnitt P/S

0.11

Aktuelles P/S

0.00

Überbewertet

1.24

Unterbewertet

-1.01

Alphio-AI-Kursszenarien für AFJK

Szenariopreise sind das letzte monatliche Prognoseband des laufenden Jahres. Die Wahrscheinlichkeiten sind feste Modellgewichte (25 / 50 / 25), keine Garantien.

B

Bullisch

Bullisch · 25%AFJK

$14.53

Szenariopreis

B

Basis

Basis · 50%AFJK

$12.44

Szenariopreis

B

Bärisch

Bärisch · 25%AFJK

$10.38

Szenariopreis

Whales, die AFJK halten

W

W. R. Berkley Corporation

+ HältAFJK

+4.37%

3-Monats-Rendite

AFJK FAQ – beantwortet von Alphio AI

Aimei Health Technology Co., Ltd. is a blank check company. The Company is formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities. The Company do not have any specific business combination under consideration and has not nor has anyone on behalf, directly or indirectly, contacted any prospective target business. It has not generated any revenues. It operates in the Financials sector.

Aimei Health Technology Co Ltd (AFJK) is currently not a strong buy. The stock is trading at $12.20, significantly down 83.92% year-to-date, indicating severe volatility and potential instability. The RSI is at 50.187, suggesting it is neither overbought nor oversold, but the forward P/E ratio is 0, indicating a lack of earnings expectations. The company has recently faced negative news, including a failure to file its quarterly report on time and the termination of a merger agreement, which has likely shaken investor confidence. The main risk is the company's recent net income drop to -83,144 USD in Q2 2026, which raises concerns about its financial health. Overall, while there may be potential for recovery, the current situation warrants a cautious approach and a hold position for now.